My Web Dashboard





SEO News: European Commission Approves Revision of Therapeutic Indication for Rebif(R) (RedNova)

GENEVA, Switzerland, July 10 /PRNewswire-FirstCall/ -- Serono (virt-x:SEO and NYSE: SRA) announced today that the European Commission has approved an update of the Summary of Product Characteristics (SmPC) of Rebif(R) (interferon beta-1a), in order to align it with current medical practice.

read more...

Related News